Kodiak Sciences Inc.

PALO ALTO, Calif., May 30, 2023 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the following upcoming investor conferences: Jefferies Healthcare Conference, June 7, 2023, 1:30 PM ET (10:30 AM PT), New … Read more

PALO ALTO, Calif., May 15, 2023 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today reported business highlights and financial results for the quarter ended March 31, 2023. “We are on the cusp of four Phase 3 study readouts … Read more